Discontinued — last reported Q3 '25
Operating
Impairment Charges
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2014
Last reportedQ3 2025
How to read this metric
An increase signals potential operational issues, poor past investment decisions, or adverse market conditions for specific business units.
Detailed definition
These are non-cash charges recorded when the carrying value of an asset exceeds its fair market value. They indicate tha...
Peer comparison
Often seen during restructuring or economic downturns across industrial sectors.
Metric ID:
impairment_charges_cfHistorical Data
14 periods
| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.35M | $586.50K | $586.50K | $586.50K | $586.50K | $0.00 | $0.00 | $0.00 | $1.48M | $250.00K | $0.00 | $0.00 | $0.00 | $5.00M |
| QoQ Change | — | -56.7% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | -83.2% | -100.0% | — | — | — |
| YoY Change | — | — | — | -56.7% | — | -100.0% | -100.0% | -100.0% | +153.0% | — | -100.0% | — | — | — |
Range$0.00 – $5.00M
CAGR+49.5%
Avg YoY Growth-50.6%
Median YoY Growth-100.0%
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's impairment charges?
- Idexx Laboratories (IDXX) reported impairment charges of $5.00M in Q1 2026.
- What does impairment charges mean?
- A write-down of an asset's value because it is worth less than what is recorded on the balance sheet.